Srinivas Viswanathan

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Srinivas Viswanathan

Mar 4, 2025, 08:01 | Blog

Dana-Farber has elected the largest cohort of physician-investigators to the 2025 class of ASCI

Dana-Farber Cancer Institute shared a post on LinkedIn "Dana-Farber has elected the largest cohort of…

Feb 8, 2025, 07:09 | Science

Srinivas Viswanathan: TFE3 fusion drives a key oxidative phosphorylation in translocation RCC

Srinivas Viswanathan, Principal Investigator at Dana-Farber Cancer Institute and an Assistant Professor at Harvard Medical…

Oct 8, 2024, 10:05 | Blog

Srinivas Viswanathan: Inspired choice for this year's Nobel in Medicine

Srinivas Viswanathan shared a post by Nature, on X, adding: "Inspired choice for this year's Nobel…

Aug 24, 2024, 06:53 | Insight

Srinivas Viswanathan: A genetic basis for sex differences in Xp11 translocation renal cell carcinoma

Recently, an article by Srinivas Viswanathan et al. titled "A genetic basis for sex differences in…

Aug 9, 2023, 19:51 | Insight

How chrX alterations may drive sex differences in cancer - Srinivas Viswanathan

Happy to share our latest collaborative preprint with CZ Zhang lab. We studied Xp11 translocation…

All: 5 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023